Creo Medical Group PLC (CREO) - Total Assets
Based on the latest financial reports, Creo Medical Group PLC (CREO) holds total assets worth GBX68.80 Million GBX (≈ $8.37K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Creo Medical Group PLC net assets for net asset value and shareholders' equity analysis.
Creo Medical Group PLC - Total Assets Trend (2005–2024)
This chart illustrates how Creo Medical Group PLC's total assets have evolved over time, based on quarterly financial data.
Creo Medical Group PLC - Asset Composition Analysis
Current Asset Composition (December 2024)
Creo Medical Group PLC's total assets of GBX68.80 Million consist of 86.8% current assets and 13.2% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 13.4% |
| Accounts Receivable | GBX1.30 Million | 2.0% |
| Inventory | GBX2.70 Million | 4.2% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX500.00K | 0.8% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2005–2024)
This chart illustrates how Creo Medical Group PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Creo Medical Group PLC market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Creo Medical Group PLC's current assets represent 86.8% of total assets in 2024, an increase from 0.0% in 2005.
- Cash Position: Cash and equivalents constituted 13.4% of total assets in 2024, up from 0.0% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
- Asset Diversification: The largest asset category is inventory at 4.2% of total assets.
Creo Medical Group PLC Competitors by Total Assets
Key competitors of Creo Medical Group PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Creo Medical Group PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.28 | 3.24 | 14.79 |
| Quick Ratio | 4.75 | 2.38 | 14.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX25.70 Million | GBX22.20 Million | GBX72.35 Million |
Creo Medical Group PLC - Advanced Valuation Insights
This section examines the relationship between Creo Medical Group PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.13 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -15.1% |
| Total Assets | GBX65.00 Million |
| Market Capitalization | $633.60K USD |
Valuation Analysis
Below Book Valuation: The market values Creo Medical Group PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Creo Medical Group PLC's assets decreased by 15.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Creo Medical Group PLC (2005–2024)
The table below shows the annual total assets of Creo Medical Group PLC from 2005 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX65.00 Million ≈ $7.91K |
-15.14% |
| 2023-12-31 | GBX76.60 Million ≈ $9.32K |
+1.68% |
| 2022-12-31 | GBX75.34 Million ≈ $9.17K |
-25.12% |
| 2021-12-31 | GBX100.61 Million ≈ $12.24K |
+8.81% |
| 2020-12-31 | GBX92.46 Million ≈ $11.25K |
+4.76% |
| 2019-12-31 | GBX88.26 Million ≈ $10.74K |
+77.43% |
| 2018-12-31 | GBX49.75 Million ≈ $6.05K |
+417.17% |
| 2018-06-30 | GBX9.62 Million ≈ $1.17K |
-40.34% |
| 2017-06-30 | GBX16.12 Million ≈ $1.96K |
+566.83% |
| 2016-06-30 | GBX2.42 Million ≈ $294.20 |
-35.60% |
| 2016-02-29 | GBX3.75 Million ≈ $456.86 |
+259.53% |
| 2015-02-28 | GBX1.04 Million ≈ $127.07 |
-35.72% |
| 2014-02-28 | GBX1.62 Million ≈ $197.70 |
+850.20% |
| 2008-02-29 | GBX171.00K ≈ $20.81 |
-33.46% |
| 2007-02-28 | GBX257.00K ≈ $31.27 |
+59.63% |
| 2006-02-28 | GBX161.00K ≈ $19.59 |
+3120.00% |
| 2005-02-28 | GBX5.00K ≈ $0.61 |
-- |
About Creo Medical Group PLC
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices deli… Read more